Australia/Canberra:
AbbVie Pty Ltd. recalls certain batch/lots of Lucrin Depot Paediatric Leuprorelin Acetate due to suspected insufficient mixing and consequential risk of incomplete delivery of medication, a serious health hazard. ACCC: http://ht.ly/xm5R30fCKOn
Additional information:
The Australian Competition & Consumer Commission (“ACCC”) reports the following Drug products are subject to this recall:
Filed under: ACCC, Drugs, Labeling or regulatory issues, Medical / Veterinary | Tagged: ACCC, ACCC PRA number: 2017/16353, Australian Competition & Consumer Commission, drug, Lucrin Depot Paediatric Leuprorelin Acetate, medical, Recalls Direct RIN: 9270-2017, risk of incomplete delivery of medication | Leave a comment »